3653 results for «269»

Filter By

3653 results

Expanding the spectrum of TEER suitability

18 Feb 2023 – From PCR Tokyo Valves 2023

Join this session to delve into diverse Transcatheter Edge-to-Edge Repair (TEER) scenarios, covering optimal patient groups for MitraClip therapy, insights from the EXPAND G4 study and the meticulous choice of four clip sizes for varying valve anatomies.

Clinical cases - Structural interventions - Session 7

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Structural interventions - Session 9

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 8

07 Oct 2022 – From AICT-AsiaPCR 2022

TAVI

18 Feb 2023 – From PCR Tokyo Valves 2023

Discover a selection of cases exploring TAVI at PCR Tokyo Valves 2023 in this session: long-term survival assessment after TAVI, cerebral embolic protection devices for stroke prevention, ultrasound-guided vs. conventional MANTA vascular closure devices, and more!

AICT-AsiaPCR 2023 Opening Ceremony

21 Sep 2023 – From AICT-AsiaPCR 2023

This opening ceremony of the 2023 edition of the AICT-AsiaPCR congress provides an opportunity for its Directors and co-Directors to present the programme, of course, but also to offer several prestigious awards, to introduce the Asian Pacific Society of Interventional Cardiology (APSIC) and its missions, and...

AICT-AsiaPCR 2023 Opening Ceremony

Percutaneous treatment of pure aortic regurgitation: a new indication

21 Sep 2023 – From AICT-AsiaPCR 2023

Analyse the case of an 83-year-old male patient with history of HT, parkinson's disease and minor stroke, who presented with worsening exertional SOB, LVEF 55-60 %, dilated LV, mild MR, and severe AR, and study the different options to treat aortic regurgitation.

Percutaneous treatment of pure aortic regurgitation: a new indication

Valve-in-valve - LIVE case

21 Sep 2023 – From AICT-AsiaPCR 2023

An 84-year-old man, with a history of 23 Carpentier-Edwards in 2004, PPM in 2013, AF on warfarin and impaired LV function (40 %), presented with severe symptomatic stenosis of the surgical bioprosthesis.

A 23 Navitor was implanted without predilatation and with post-dilatation under cerebral protection (Sentinel).

Closure was...

Valve-in-valve- AICT-AsiaPCR 2023

Intercostal embolization of a stuck rotational atherectomy burr

02 Mar 2021

An elective right coronary artery PCI was scheduled in an 83-year-old gentleman. Due to the presence of severely diffuse and calcified disease, rotational atherectomy was decided, but the burr got entrapped in the severely calcified and tortuous proximal segment of the artery...

Embolization of a rotational atherectomy burr

RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

01 Sep 2024

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Nicola Ryan

Author

Nicola Ryan
RESHAPE-HF2

GLORIOUS - Efficacy of restrictive versus liberal oxygenation or Exenatide in patients undergoing coronary artery bypass grafting or aortic valve replacement – a randomised clinical trial

21 Nov 2024

Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.

Edoardo Zancanaro

Author

Edoardo Zancanaro
GLORIOUS

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

03 Sep 2025

Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author

Aaysha Cader
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?